Sugemalimab is the world's first anti-PD-L1 monoclonal antibody approved for use in combination with fluorouracil and platinum-based chemotherapy for unresectable...
BEIJING, Dec. 8, 2023 /PRNewswire/ -- iQIYI, an innovative market-leading online entertainment service in China, attended the 2023 Asia TV...
~ King's University College and UEL sign MoU to unite for a Five-Year Partnership ~ HO CHI MINH CITY, Vietnam,...
Dubai, UAE, Dec. 8, 2023 /PRNewswire/ -- Optasia, a leading Fintech services provider, proudly announces the deployment of its Airtime...
AUBURN HILLS, Mich., Dec. 8, 2023 /PRNewswire/ -- Nexteer Automotive has been awarded on Newsweek's list of America's Most Responsible Companies...
GEMBLOUX, Belgium, Dec. 8, 2023 /PRNewswire/ -- Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced the construction of...
HONG KONG, Dec. 8, 2023 /PRNewswire/ -- A randomised, double-blind, placebo-controlled trial (RECOVERY STUDY) conducted by The Chinese University of Hong...
SHANGHAI, Dec. 8, 2023 /PRNewswire/ -- Aon plc (NYSE: AON), a leading global professional services firm, today announced it has...
© 2022 Siam News Network - Thailand Business News and advertising Network. Powered by VLoss.
© 2022 Siam News Network - Thailand Business News and advertising Network. Powered by VLoss.